A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Forza Innovations's Debt-to-EBITDA or its related term are showing as below:
FORZ's Debt-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.555 * Ranked among companies with meaningful Debt-to-EBITDA only.
Forza Innovations (OTCPK:FORZ) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Forza Innovations Debt-to-EBITDA Related Terms
Forza Innovations Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Forza Innovations's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FORZ vs USAQ, EMED, RTSL: Debt-to-EBITDA Comparison
For the Medical Devices subindustry, Forza Innovations's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Forza Innovations Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Forza Innovations's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Forza Innovations's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.
Forza Innovations (FORZ) has a Debt-to-EBITDA of 0.50 as of Dec. 2023. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Forza Innovations.
Is Forza Innovations' Debt-to-EBITDA too high?
Forza Innovations' current Debt-to-EBITDA is 0.50. The Medical Devices & Instruments industry median Debt-to-EBITDA is 1.56. Forza Innovations' value of 0.50 is 67.8% below this industry median.
How does Forza Innovations' Debt-to-EBITDA compare to USAQ and EMED?
Forza Innovations' Debt-to-EBITDA of 0.50 can be compared against companies in the Medical Devices & Instruments industry. The industry median Debt-to-EBITDA is 1.56. Forza Innovations' value of 0.50 is 67.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.56, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Forza Innovations's current Debt-to-EBITDA of 0.50 is 67.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Forza Innovations. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Forza Innovations's current Debt-to-EBITDA is 0.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Forza Innovations stock overvalued right now?
Forza Innovations (FORZ) has a current Debt-to-EBITDA of 0.50. The current Debt-to-EBITDA is 0.50 and 67.8% below the Medical Devices & Instruments industry median of 1.56. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Forza Innovations (FORZ), the current Debt-to-EBITDA is 0.50 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Forza Innovations Inc is in the health-tech wearable performance business. The company has acquired all the ownership and rights to certain late developmental-stage products, including the J4 Sport, J4 X, and J4 Fitbelt. These products are wearable back compression devices, used to relax, warm up, loosen, or relax stiff & sore muscles. The therapeutic application of heat causes a change in the temperature of the soft tissues which decreases joint stiffness and relieves inflammation.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FORZ has been successfully added to your 